SCHEMBL4865149

SCHEMBL4865149

CC(NC(=O)OCc1ccccc1)C(=O)NC1CCC(Cc2ccccc2Cl)(N(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
GAA P10253 1/20 0.45
CYP1A2 P05177 3/20 0.45
TSHR P16473 7/20 0.44
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
CTSK P43235 5/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CYP3A4 P08684 7/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CASP1 P29466 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 4/20 0.41
CYP2C19 P33261 3/20 0.41
CYP2D6 P10635 2/20 0.41
PREP P48147 2/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868422 0.90 CYP1A2 (0.48) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4868448 0.90 CYP1A2 (0.50) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4871921 0.90 CTSL (0.47) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4861833 0.88 MEN1 (0.46) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4871703 0.87 CYP1A2 (0.44) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4863435 0.85 CYP1A2 (0.46) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4865497 0.84 CYP1A2 (0.48) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4861760 0.84 CYP1A2 (0.45) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4864984 0.83 CYP1A2 (0.44) ALDH1A1GAACYP1A2TSHRMEN1
SCHEMBL4871805 0.80 CTSL (0.50) CTSKCTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751090-B1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES GRUENENTHAL GMBH (DE) 2014-10-08 EP claimed
US-7439394-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2008-10-21 US claimed
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-24 US claimed
US-7439394-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2008-10-21 US disclosed
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885GAA 20/4885CYP1A2 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.